Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Deutsche Bank upgraded Boston Scientific (BSX) to Buy from Hold with a price target of $108, up from $87. Boston Scientific’s :story has become ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

The stock market suffered damaging losses with the S&P 500 and Nasdaq below their 50-day lines as Treasury yields leaped.

FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Australia's Rinky Hijikata continues to make the most of his late call-up at the Adelaide International, advancing to the quarterfinals with a tough three-set win over Brandon Nakashima.

Dec. 18, 2024 — Researchers studied oxygen treatment as a potential therapy to target specific cells linked to the development of cardiovascular and metabolic disorders like high blood pressure ...

Real estate giant Dar Global said it plans to expand in the U.S. and Greece after the Dubai-based developer recently unveiled projects in partnership with the Trump Organization, Reuters reported ...